Radiopharmaceuticals: Resolving an Enigma
Healthcare Unfiltered
00:00
Radiation Oncology
One of the challenge is that these two different molecules. The diagnostic molecule is gallium ps may eleventh, a little bit different in the lutitium, ps ma six one sevend. There are some agents that are occurrently being explored with, say, copper 64 and copper 67,. But even that differs a little bit because they're only getting one point time when you're doing dosymmetry tests. Sometimes what we would really like to see is an agent that emits o both the therapeutic and diagnostic at the same time. And you can monitor that in of the uptake.
Transcript
Play full episode
